What is Fluidic Sciences?
Fluidic Sciences, established in 2013 as a spin-out from the University of Cambridge's Department of Chemistry, is a UK-based company specializing in the design, development, and manufacturing of innovative tools for protein characterization. Their technology serves laboratory, medical, and consumer applications, offering fast, convenient, and accurate analysis. The company's operations are rooted in deep scientific expertise, positioning it as a key player in the advanced diagnostics and life sciences sector. The substantial enterprise-level funding indicates a strong market validation for its proprietary technologies.
How much funding has Fluidic Sciences raised?
Fluidic Sciences has raised a total of $40.3M across 3 funding rounds:
Series A
$2.4M
Series B
$6.9M
Unspecified
$31M
Series A (2015): $2.4M with participation from Amadeus Capital Partners, Cambridge Enterprise, Parkwalk Advisors, and DFJ Esprit
Series B (2016): $6.9M led by Amadeus Capital Partners, Cambridge Enterprise, IQ Capital Partners, Molten, Cambridge Innovation Capital, and Parkwalk Advisors
Unspecified (2018): $31M supported by Amadeus Capital Partners, Delin Ventures, IQ Capital, BGF, and Molten
Key Investors in Fluidic Sciences
Amadeus Capital Partners
Amadeus Capital Partners is a London-based global technology venture capital firm that invests in high-growth companies from seed to later stages across sectors such as artificial intelligence, digital health, cybersecurity, enterprise software, fintech, and deep tech.
IQ Capital
IQ Capital is a venture capital firm, based in Cambridge and London, investing in 'deep-tech' across sectors including machine learning, AI, robotics, and advanced engineering and materials. They have a strong track record of supporting companies capable of global market dominance.
BGF
BGF, headquartered in London, United Kingdom, is the most active and influential investor in small and mid-sized businesses in the UK, supporting a range of growing companies across every region and sector of the economy.
What's next for Fluidic Sciences?
With a substantial funding history culminating in a major strategic investment, Fluidic Sciences is poised for accelerated growth and market penetration. The company's focus on protein characterization tools suggests a strategic expansion into areas such as drug discovery, personalized medicine, and advanced diagnostics. Future developments are likely to involve scaling manufacturing capabilities, enhancing product offerings, and potentially exploring new application areas. The consistent backing from prominent technology investors signals confidence in Fluidic Sciences' long-term vision and its capacity to innovate within the competitive life sciences landscape.
See full Fluidic Sciences company page
